We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAY:LSEMayflower Acquisition Ltd. Analysis

Data as of 2026-03-10 - not real-time

$9.75

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Mayflower Acquisition Limited (MAY.L) is trading at a flat $9.75, exactly at its identified support level, suggesting limited upside unless a breakout occurs. The stock sits below its 20‑day SMA of 9.89 and the 50‑day SMA of 10.12, reinforcing a short‑term bearish bias. However, the MACD histogram has turned positive and the MACD signal is flagged as bullish, hinting at a possible technical reversal. RSI is at 36, still above the oversold threshold of 30, indicating modest buying pressure but not a strong rebound yet. Volume trends are decreasing, with average daily volume far below the 10‑day average, which may limit price discovery. Volatility over the past 30 days is elevated at ≈ 17.8%, and the beta of ‑0.12 suggests the stock moves independently of broader market swings.
The company reports zero revenue, earnings, or cash balances, reflecting its status as a newly incorporated shell awaiting a merger or acquisition. Consequently, traditional valuation multiples are unavailable, and the market cap of ≈ $480 million appears speculative. The fear‑and‑greed index reads 76.9, labeled Extreme Greed, implying market participants may be over‑optimistic despite limited fundamentals. The maximum drawdown of ‑11.4% and a bearish trend direction further underscore the downside risk. Given the lack of dividend policy and the uncertainty surrounding a future business combination, dividend sustainability is effectively false. Investors should weigh the technical hints of a rebound against the structural uncertainties before deciding on exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price at support level
  • decreasing volume
  • bearish SMA alignment

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential MACD reversal
  • absence of financial fundamentals
  • elevated volatility

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • possibility of a merger or acquisition
  • shell structure offering upside
  • market sentiment reflected by extreme greed

Key Metrics & Analysis

Financial Health

Industry P/E17.3

Technical Analysis

TrendBearish
RSI36.3
Support$9.75
Resistance$10.50
MA 20$9.89
MA 50$10.12
MA 200$10.22
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.12
Volatility17.77%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.